KANSAS CITY, Kan., June 23, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery ...
Patients with first-episode MDD showed lower effective and functional connectivity between the anterior cingulate cortex and frontal regions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback